Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 220

1.

Connections between vascular calcification and progression of chronic kidney disease: therapeutic alternatives.

Hruska KA, Mathew S, Davies MR, Lund RJ.

Kidney Int Suppl. 2005 Dec;(99):S142-51.

PMID:
16336568
2.

Bone morphogenetic proteins in vascular calcification.

Hruska KA, Mathew S, Saab G.

Circ Res. 2005 Jul 22;97(2):105-14. Review.

3.

Bone morphogenetic protein 7: a novel treatment for chronic renal and bone disease.

Li T, Surendran K, Zawaideh MA, Mathew S, Hruska KA.

Curr Opin Nephrol Hypertens. 2004 Jul;13(4):417-22. Review.

PMID:
15199292
4.

Bone health and vascular calcification relationships in chronic kidney disease.

Spasovski GB.

Int Urol Nephrol. 2007;39(4):1209-16. Epub 2007 Sep 26. Review.

PMID:
17899431
5.

Arterial accelerated aging in dialysis patients: the clinical impact of vascular calcification.

Brancaccio D, Bellasi A, Cozzolino M, Galassi A, Gallieni M.

Curr Vasc Pharmacol. 2009 Jul;7(3):374-80. Review.

PMID:
19601862
6.

Pathophysiology of vascular calcification in chronic kidney disease.

Moe SM, Chen NX.

Circ Res. 2004 Sep 17;95(6):560-7. Review.

7.

Renal osteodystrophy, phosphate homeostasis, and vascular calcification.

Hruska KA, Saab G, Mathew S, Lund R.

Semin Dial. 2007 Jul-Aug;20(4):309-15. Review.

PMID:
17635820
8.

Osteogenic regulation of vascular calcification: an early perspective.

Vattikuti R, Towler DA.

Am J Physiol Endocrinol Metab. 2004 May;286(5):E686-96. Review.

9.

Derangements in phosphate metabolism in chronic kidney diseases/endstage renal disease: therapeutic considerations.

Molony DA, Stephens BW.

Adv Chronic Kidney Dis. 2011 Mar;18(2):120-31. doi: 10.1053/j.ackd.2011.02.004. Review.

PMID:
21406297
10.

Vascular calcification in chronic kidney disease.

Jono S, Shioi A, Ikari Y, Nishizawa Y.

J Bone Miner Metab. 2006;24(2):176-81. Review.

PMID:
16502129
11.

Rheumatic manifestations of renal disease.

Bardin T, Richette P.

Curr Opin Rheumatol. 2009 Jan;21(1):55-61. doi: 10.1097/BOR.0b013e32831ca5c5. Review.

PMID:
19077720
12.

Vascular calcification and arterial stiffness in chronic kidney disease: implications and management.

Toussaint ND, Kerr PG.

Nephrology (Carlton). 2007 Oct;12(5):500-9. Review.

PMID:
17803475
13.

Determinants of coronary vascular calcification in patients with chronic kidney disease and end-stage renal disease: a systematic review.

McCullough PA, Sandberg KR, Dumler F, Yanez JE.

J Nephrol. 2004 Mar-Apr;17(2):205-15. Review.

PMID:
15293519
14.

[Management of hyperphosphatemia ; phosphate-binder].

Yokoyama K.

Clin Calcium. 2009 Feb;19(2):205-12. doi: CliCa0902205212. Review. Japanese.

PMID:
19182360
15.

Ten-year experience with sevelamer and calcium salts as phosphate binders.

Raggi P, Vukicevic S, Moysés RM, Wesseling K, Spiegel DM.

Clin J Am Soc Nephrol. 2010 Jan;5 Suppl 1:S31-40. doi: 10.2215/CJN.05880809. Review.

16.

Management of vascular calcification in CKD patients.

Massry SG, Smogorzewski M.

Semin Nephrol. 2006 Jan;26(1):38-41. Review.

PMID:
16412824
18.

[Roles of hyperphosphatemia in vascular calcification].

Shioi A, Nishizawa Y.

Clin Calcium. 2009 Feb;19(2):180-5. doi: CliCa0902180185. Review. Japanese.

PMID:
19182356
19.

Prevention and control of phosphate retention/hyperphosphatemia in CKD-MBD: what is normal, when to start, and how to treat?

Martin KJ, González EA.

Clin J Am Soc Nephrol. 2011 Feb;6(2):440-6. doi: 10.2215/CJN.05130610. Epub 2011 Feb 3. Review.

20.

Diagnostic procedures and rationale for specific therapies in chronic kidney disease-mineral and bone disorder.

Bover J, Canal C, Marco H, Fernandez-Llama P, Bosch RJ, Ballarín J.

Contrib Nephrol. 2008;161:222-33. doi: 10.1159/000130690. Review.

PMID:
18451681
Items per page

Supplemental Content

Write to the Help Desk